929 results on '"Sukumar, Saraswati"'
Search Results
2. Perturbed myoepithelial cell differentiation in BRCA mutation carriers and in ductal carcinoma in situ.
3. Quantitative phosphoproteomic analysis reveals reciprocal activation of receptor tyrosine kinases between cancer epithelial cells and stromal fibroblasts
4. Correction to: Quantitative phosphoproteomic analysis reveals reciprocal activation of receptor tyrosine kinases between cancer epithelial cells and stromal fibroblasts
5. CRYβB2 enhances tumorigenesis through upregulation of nucleolin in triple negative breast cancer
6. HOX genes and the NF-κB pathway: A convergence of developmental biology, inflammation and cancer biology
7. Characteristics and antitumor activity of polysorbate 80 curcumin micelles preparation by cloud point cooling
8. High-performance methylated DNA markers for the detection of cervical lesions at risk of malignant progression in low- and middle-income countries
9. High performance methylated DNA markers for detection of colon adenocarcinoma
10. Methylated markers accurately distinguish primary central nervous system lymphomas (PCNSL) from other CNS tumors
11. Automated and rapid detection of cancer in suspicious axillary lymph nodes in patients with breast cancer
12. Multiple roles of HOX proteins in Metastasis: Let me count the ways
13. Unpredicted central inversion in a sgRNA flanked by inverted repeats
14. Intraductal Therapy in Breast Cancer: Current Status and Future Prospective
15. Targeted nanopore sequencing with Cas9-guided adapter ligation
16. Erratum to: Modeling precision treatment of breast cancer.
17. Data from Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer
18. Supplementary Data from Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer
19. Modeling precision treatment of breast cancer
20. DNA methylation markers predict recurrence-free interval in triple-negative breast cancer
21. Nanoparticle-Based Combination Therapy Enhances Fulvestrant Efficacy and Overcomes Tumor Resistance in ER-Positive Breast Cancer
22. High Frequency of Hypermethylation at the 14-3-3 σ Locus Leads to Gene Silencing in Breast Cancer
23. Guidelines for the selection of functional assays to evaluate the hallmarks of cancer
24. Data from Development of an Automated Liquid Biopsy Assay for Methylated Markers in Advanced Breast Cancer
25. Supplementary Fig S3 from Development of an Automated Liquid Biopsy Assay for Methylated Markers in Advanced Breast Cancer
26. Supplementary Table S1 from Development of an Automated Liquid Biopsy Assay for Methylated Markers in Advanced Breast Cancer
27. Data from Improvement of Stability and Efficacy of C16Y Therapeutic Peptide via Molecular Self-Assembly into Tumor-Responsive Nanoformulation
28. Data from Gene Methylation and Cytological Atypia in Random Fine-Needle Aspirates for Assessment of Breast Cancer Risk
29. Data from Big Punches Come in Nanosizes for Chemoprevention
30. Related Article from Big Punches Come in Nanosizes for Chemoprevention
31. Supplementary Figure 1 from Gene Methylation and Cytological Atypia in Random Fine-Needle Aspirates for Assessment of Breast Cancer Risk
32. Supplemental Tables 1-3 from Breast Hormone Concentrations in Random Fine-Needle Aspirates of Healthy Women Associate with Cytological Atypia and Gene Methylation
33. Data from HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance
34. Supplementary Tables S1 to S9 from Gene Methylation and Cytological Atypia in Random Fine-Needle Aspirates for Assessment of Breast Cancer Risk
35. Supplementary Materials and Methods; Supplementary Table S1; Supplementary Figures S1-S5 from Improvement of Stability and Efficacy of C16Y Therapeutic Peptide via Molecular Self-Assembly into Tumor-Responsive Nanoformulation
36. Data from Breast Hormone Concentrations in Random Fine-Needle Aspirates of Healthy Women Associate with Cytological Atypia and Gene Methylation
37. Supplementary Methods, Figures S1 - S10, Tables S1 - S2 from HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance
38. Supplementary Data from HOXA5-Mediated Stabilization of IκBα Inhibits the NF-κB Pathway and Suppresses Malignant Transformation of Breast Epithelial Cells
39. Supplementary Figure 1 from Biomarker Modulation following Short-Term Vorinostat in Women with Newly Diagnosed Primary Breast Cancer
40. Supplementary Data from Heterogeneity of Breast Cancer Metastases: Comparison of Therapeutic Target Expression and Promoter Methylation Between Primary Tumors and Their Multifocal Metastases
41. Supplementary Legend from Biomarker Modulation following Short-Term Vorinostat in Women with Newly Diagnosed Primary Breast Cancer
42. Supplementary methods and figures S1-S8 from Targeting Glutamine Metabolism in Breast Cancer with Aminooxyacetate
43. Supplementary Figure Legends 1-6 from SLITs Suppress Tumor Growth In vivo by Silencing Sdf1/Cxcr4 within Breast Epithelium
44. Supplementary Table 6 from Genetic and Phenotypic Diversity in Breast Tumor Metastases
45. Supplementary Table 2 from Epigenetic Inactivation of the Potential Tumor Suppressor Gene FOXF1 in Breast Cancer
46. Supplementary Figures 1-7 from Hoxb7 Inhibits Transgenic HER-2/neu–Induced Mouse Mammary Tumor Onset but Promotes Progression and Lung Metastasis
47. Supplementary Figure Legends 1-7 from Hoxb7 Inhibits Transgenic HER-2/neu–Induced Mouse Mammary Tumor Onset but Promotes Progression and Lung Metastasis
48. Supplementary Table 3 from Genome-wide Methylation Analysis Identifies Genes Specific to Breast Cancer Hormone Receptor Status and Risk of Recurrence
49. Supplementary Table 5 from Genetic and Phenotypic Diversity in Breast Tumor Metastases
50. Data from Epigenetic Inactivation of the Potential Tumor Suppressor Gene FOXF1 in Breast Cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.